ArticleFrontline gastroenterology2016

Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab.

Saqib Mumtaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.